Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heartbeam Inc (NQ: BEAT ) 2.400 +0.110 (+4.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Heartbeam Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Earnings Preview For HeartBeam March 15, 2023 Via Benzinga BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Acquires LIVEMOR Assets March 14, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property HeartBeam Announces Acquisition of LIVMOR Assets March 14, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products March 13, 2023 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Makes Changes in Senior Leadership Roles March 08, 2023 Via Investor Brand Network Exposures Product Safety HeartBeam Announces Senior Leadership Change March 08, 2023 From HeartBeam, Inc. Via Business Wire Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives March 06, 2023 While there can be some value in having a single-lead ECG always available, patients with known heart conditions need much better technology. Via Talk Markets HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact March 03, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Thursday's After-Market Session March 02, 2023 Via Benzinga BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call March 02, 2023 Via Investor Brand Network HeartBeam to Host Fourth Quarter and Full Year 2022 Results Conference Call on Thursday March 16, 2023 at 4:30 p.m. Eastern Time March 02, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview February 21, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions February 21, 2023 Via Investor Brand Network BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks February 03, 2023 Via Investor Brand Network BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President January 24, 2023 Via Investor Brand Network HeartBeam Appoints Robert Eno as President January 24, 2023 From HeartBeam, Inc. Via Business Wire HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space January 24, 2023 Via Investor Brand Network BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Growing Patent Portfolio Poised to Have Disruptive Effect on Multibillion Markets January 19, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Traders News Source Interview January 12, 2023 Via Investor Brand Network CEO & Founder of Heartbeam Inc. Discusses the Potential for the AIMI(TM) and AIMIGo(TM) Technology in an Audio Interview with TradersNewsSource.com January 12, 2023 Via ACCESSWIRE BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Receives Key Patent from European Patent Office January 05, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG) January 05, 2023 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Shareholder Letter, Including Corporate Update December 29, 2022 Via Investor Brand Network Exposures Product Safety HeartBeam Issues Shareholder Letter and Provides Corporate Update December 29, 2022 From HeartBeam, Inc. Via Business Wire HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology December 21, 2022 Via Investor Brand Network HeartBeam (NASDAQ: BEAT) Looks to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product December 20, 2022 By Spotlight Growth Via News Direct HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection December 19, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Renowned Cardiologist to Help Define Best Paths to Advance Products December 16, 2022 Via Investor Brand Network HeartBeam (NASDAQ: BEAT) Looks to Disrupt Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product December 15, 2022 Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few years ago, heart patients seeking to have their condition monitored... Via Benzinga HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product December 15, 2022 Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few Via Spotlight Growth < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.